Friday, November 11, 2011

Teva planning to cut 1,500 jobs at Cephalon - PMLiVE

Teva is reportedly planning to lay-off up to 1,500 staff at Cephalon, less than a month after it acquired the US biopharmaceuticals firm.

After agreeing the $6.8bn deal earlier this year Teva said it would lead to $500m worth of synergies, a substantial part of which would come form the elimination of duplicate activities, but the Israeli pharma company has yet to confirm any details.

Posted via email from Jack's posterous

No comments: